Interestingly, cannabinoid receptors, such as CB2, have been shown to undergo a major upregulatory response in the spinal cord of mouse models of ALS at symptomatic stages, including SOD1 mutants [14, 28] and TDP‐43 transgenic mice [15, 29]. Here, CNR2 is linked to amyotrophic lateral sclerosis.